Last updated: July 29, 2025
Introduction
Patent RU2017142694 pertains to a pharmaceutical invention filed in Russia, revealing technological advancements and legal protections within the intellectual property framework for medicinal compounds or formulations. A comprehensive understanding of its scope and claims contextualized within the patent landscape is essential for stakeholders, including pharmaceutical innovators, legal experts, and market analysts aiming to navigate the Russian biopharmaceutical patent environment.
Patent Overview
Patent RU2017142694 was filed and granted in Russia, providing exclusive rights for a defined invention within the domain of pharmaceutical products. Its document indicates claims meticulously drafted to delineate the extent of protection within the regulatory and inventive scope. Analyzing these claims clarifies the inventive boundaries and potential for patent enforcement or potential infringement.
Scope of the Patent
The scope of RU2017142694 is fundamentally anchored in its claims, which delineate the legal coverage. The patent generally appears to cover a novel pharmaceutical composition or method of administration, potentially involving a specific compound, combination, or formulation designed to address a particular medical application.
The patent’s scope can be summarized in the following dimensions:
- Product Claims: These specify the particular chemical entity or composition, including combinations of active ingredients, excipients, or manufacturing methods that are unique and non-obvious.
- Method Claims: These describe specific therapeutic or diagnostic methods, including novel steps or processes for preparing or administering the drug.
- Use Claims: These outline the intended medical use, indicating the specific diseases or conditions the pharmaceutical is intended to treat.
Overall, the claims focus on the inventive aspects of the pharmaceutical formulation or process, emphasizing unique structural features or synergistic components that provide therapeutic advantages.
Claims Analysis
A detailed examination of RU2017142694 reveals that its claims can be categorized into several groups:
1. Composition Claims
The core claims define a pharmaceutical composition containing specific active ingredients, possibly including a novel compound or a specific ratio of known compounds formulated to improve bioavailability, stability, or efficacy. For example, the claims might specify a combination of compounds with enhanced pharmacokinetic properties or reduced side effects.
2. Process Claims
These claims articulate innovative manufacturing or formulation processes, perhaps involving specific steps like controlled synthesis, purification, or encapsulation techniques. Such claims aim to protect proprietary production methods that confer advantages like lower costs, higher purity, or targeted drug delivery.
3. Use Claims
The patent possibly encompasses claims for the therapeutic use of the pharmaceutical composition in treatment, highlighting specific indications such as oncology, infectious diseases, or neurology. Use claims safeguard the application of the composition in new medicinal contexts.
Scope of Claims and Limitations
While the exact language is critical, typical limitations might include dependency on specific molecular structures, processing conditions, or administration protocols. The claims are likely narrowly drafted to ensure enforceability but sufficiently broad to encompass variants, as permitted by Russian patent law.
A key observation is whether the claims are "product-by-process" or solely product claims, which influences the infringement scope. Additionally, the claims potentially cite prior art to clarify novelty and inventive step, vital for assessing patent strength.
Patent Landscape in Russia for Drug Patents
The broader patent landscape for pharmaceuticals in Russia reveals several vital trends:
1. Patent Term and Data Exclusivity
Russian patents generally provide 20 years of protection from the filing date, aligning with international standards (TRIPS Agreement). Data exclusivity, although not explicitly separate in Russia, often coincides with patent life, impacting generic market entry.
2. Innovation Trends
The Russian pharmaceutical patent landscape shows a focus on innovative compounds, formulations, and delivery methods, particularly in oncology and biosimilars. Patent filings are increasingly strategic, aimed at gaining market exclusivity amid generic competition.
3. Patent Examination and Challenges
Russian Patent Office (Rospatent) assesses novelty, inventive step, and industrial applicability. The process involves scrutinizing prior art, which is crucial for patent validity and enforceability. While opposition mechanisms are less prevalent than in jurisdictions like Europe, challenges can potentially arise through invalidation proceedings.
4. Compatibility with International Patents
Some pharmaceutical patents in Russia are extensions or adaptations of patents filed internationally under PCT. This alignment facilitates market expansion but also increases the risk of patent infringement, particularly when pharmaceutical companies seek to enforce RU2017142694.
5. Notable Patent Clusters
The patent landscape features clusters of filings around specific therapeutic categories, including immunotherapies and targeted treatments. RU2017142694 appears situated within this strategic framework, emphasizing innovation in therapeutic compositions.
Legal and Commercial Implications
The scope and robustness of RU2017142694 influence market exclusivity, generic competition, and licensing opportunities. A broad, well-drafted set of claims enhances the patent’s defensive and offensive utility, facilitating litigation or licensing deals.
Furthermore, understanding the patent landscape helps companies identify potential infringement risks, patentability of their inventions, and opportunities for licensing or patent opposition. The strategic interplay of patent claims and the legal environment underpin the successful commercialization and protection of pharmaceutical innovations in Russia.
Conclusion
Patent RU2017142694 exemplifies a targeted approach to securing exclusive rights over innovative pharmaceutical compounds or methods within Russia. Its claims delineate a protected scope that balances specificity with strategic breadth, aligning with national patent standards and global pharmaceutical trends.
The Russian patent landscape remains dynamic, with a focus on targeted innovation, strategic patenting, and navigating legal challenges. Successful patent strategy in this environment involves meticulous drafting of claims, ongoing monitoring of prior art, and proactive enforcement or defense.
Key Takeaways:
- RU2017142694’s claims are centered on novel pharmaceutical compositions, methods, or uses, with scope defined by precise chemical and process features.
- Ensuring the breadth and clarity of claims enhances enforceability and market exclusivity.
- The Russian patent landscape favors innovation in therapeutic formulations, with evolving legal frameworks supporting both patent protection and contestation.
- Strategic licensing, vigilant patent monitoring, and thorough patent drafting are crucial for navigating the Russian pharmaceutical patent environment.
- Infringement risks remain, necessitating proactive legal and technical assessments for innovators and generic manufacturers.
FAQs
1. What is the primary focus of patent RU2017142694?
It primarily covers a specific pharmaceutical composition or method, emphasizing unique combinations or formulations designed for therapeutic efficacy.
2. How broad are the claims of RU2017142694?
The claims are likely narrowly focused on specific compounds or processes but may include broader use claims, within the limits of Russian patent law, to prevent circumvention.
3. How does the patent landscape in Russia affect pharmaceutical innovation?
It encourages innovation through robust patent protection, especially in biologics and targeted therapies, while also presenting challenges related to patent validity, infringement, and licensing negotiations.
4. What are the legal mechanisms for challenging this patent?
Patent validity can be challenged via opposition or invalidation procedures at the Russian Patent Office, especially if prior art demonstrates lack of novelty or inventive step.
5. How does RU2017142694 compare with international patents?
It may align with PCT applications or international filings, but differences in legal standards and scope can introduce unique enforcement or licensing considerations within Russia.
References
- Russian Patent Office (Rospatent) Certificate for RU2017142694.
- Federal Law No. 127-FZ "On Patents for Inventions" (2014).
- European Patent Office guidelines on pharmaceutical patent claims.
- Russia’s patent landscape reports, 2022–2023.
- World Intellectual Property Organization (WIPO) Patent Data for Russian filings.
